Clinical Trials for OX2 Therapeutics

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: OX2 Therapeutics

Clinical Trials (1)

CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young Adults

PHASE1Recruiting

24 participants

Started: Mar 15, 2024 · Completed: Jan 15, 2027

2 conditions1 sponsor1 location